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Introduction
Breast cancer is the most common type of female 
cancer worldwide which represents about a quarter (23%) 
of all cancers in women (Ferlay et al., 2012), and its 
rate of incidence and mortality are annually increasing. 
About 63,410 cases of female breast carcinoma in situ 
and 74,680 cases of melanoma in situ were expected 
to be diagnosed in the United States in 2017 (Siegel et 
al., 2017). The incidence of breast cancer in India has 
surpassed cervical cancer, which was earlier considered to 
be the most common cancer among Indian women. Breast 
cancer has now become the leading cause of cancer death 
among Indian women (Kaarthigeyan, 2012). A significant 
increase in the incidence of cancer and cancer-associated 
morbidity and mortality has been observed in the 
Indian subcontinent, as reported by a number of studies 
(Srinath et al., 2005; Ali et al., 2011; Babu et al., 2013; 
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Balasubramaniam et al., 2013). A 13.82% increase in the 
rate of mortality and 11.54% increase in the rate of cancer 
incidence have been seen in India, due to breast cancer 
during 2008–2012 (Ferlay et al., 2012). This observed hike 
in mortality may be attributed to lack of adequate strategies 
for breast cancer screening, diagnosis of the disease at an 
advanced stage and inappropriate medical facilities. 
Vitamin D has classically been associated with the 
maintenance of calcium and phosphorous homeostasis 
in the body. Besides the classical biological effects of 
vitamin D on calcium and phosphorous homeostasis, 
calcitriol, the active form of vitamin D, is known to exert 
a broad variety of actions including various anticancer 
effects which may be mediated either transcriptionally 
and/or via non-genomic pathways (Haussler et al., 
2011). Vitamin D is involved in cell cycle regulation, 
induction of apoptosis, promoting cell differentiation and 
also known to act as an anti-inflammatory factor within 
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the tumor microenvironment (Deeb et al., 2007). The 
protective action of vitamin D has also been implicated 
as a suppressor of cancer cell invasion, angiogenesis 
and metastasis (Lopes et al., 2012). Like other cancers, 
breast cancer is a multistep process with multifactorial 
involvement of genetic and environmental factors. 
Environmental exposure to lower level of UV radiation, 
which is essential for the synthesis of vitamin D, may 
be a risk factor for higher cancer incidence of many 
types including breast cancer (Finkelmeier et al., 2014). 
Biosynthesis of vitamin D starts with the non-enzymatic 
conversion of 7-dehydrocholesterol (pro-vitamin D) 
to cholecalciferol (pre-vitamin D). Cholecalciferol 
is transported to the liver where it gets hydroxylated 
by the enzyme 25-hydroxylase (in liver) to form 
25-hydroxyvitamin D, also known as calcidiol, the most 
abundant and stable vitamin D metabolite. Calcidiol is 
further hydroxylated by the enzyme 1-α-hydroxylase 
(in kidney) to 1, 25-dihydroxyvitamin D or calcitriol 
(Khokhar, 2012), the most active metabolite of vitamin D 
(Penna-Martinez et al. 2012) and binds nuclear vitamin D 
receptor (VDR) in target organs. A number of researchers 
have shown an association between vitamin D levels and 
breast cancer (Zerwekh, 2008; Yao et al., 2012; Shaukat 
et al., 2017). It is possible that the genetic variants of 
vitamin D metabolizing genes can alter the bioavailability 
of vitamin D and thus modulate the risk of breast cancer. 
Vitamin D, a steroid hormone, exerts most of its 
biological activities by binding to a specific high-affinity 
receptor, the VDR. VDR allows the body to respond to 
vitamin D in an appropriate manner (Deeb et al., 2007). 
VDR belongs to the superfamily of nuclear receptors 
(NRs) for steroid hormones and regulates gene expression 
by acting as a ligand activated transcription factor (Díaz 
et al., 2015; Yang et al., 2017) and, therefore, represents 
an important drug target which may directly be linked 
to a number of severe diseases. VDR is a member of 
superfamily of proteins which are known to contain 
amino acid homologies within two separate functional 
domains and exerts the transcriptional activation and 
repression of a number of target genes by binding to 
nuclear VDR (Feldman et al., 2014). The genomic 
mechanism of transcriptional activation by VDR involves 
recognition and binding to the vitamin D response 
elements (VDREs) in promoter regions of target genes, 
through the DNA-binding domain (Feldman et al., 2014). 
Genetic polymorphisms of VDR may modulate the risk 
of breast cancer by altering its expression as well as 
function in breast cell. The gene encoding the human 
VDR is located on the long arm of chromosome 12 i.e. 
12q.13.11 (NCBI GeneID: 7421) and harbours several 
polymorphisms in the coding and non-coding regions. A 
number of single nucleotide polymorphisms (SNPs) have 
been identified to be located in the VDR gene promoter 
region, in and around exon 2-9 and in the 3´ UTR region 
(Uitterlinden et al., 2004; Fang et al., 2005). Functional 
genetic polymorphisms that lead to an alteration in the 
regulation of gene expression are predicted to have a 
significant influence on disease pathogenesis (Pastinen et 
al., 2006). The allelic variants of the human VDR gene 
may, therefore, be risk factors for a variety of diseases 
including breast cancer. 
One of the VDR polymorphisms to be commonly 
found is the 5’ Fok1 site (rs2228570) in exon 2 (Berndt 
et al., 2006) resulting in thymine (T) to cytosine (C) 
substitution. In the present study, we analysed the 
distribution of Fok1 VDR gene polymorphism in the North 
Indian population and its association with breast cancer. 
An in silico exploration of the probable mechanism of 
increased risk of breast cancer with the Fok1 polymorph 
of the VDR was performed to explore the mechanism 




Ethical approval for the study was obtained from 
the Institutional Ethics Committee, King George 
Medical University, Lucknow (Ref. no. 78th ECM 
IIB-Ph.D./P2/2016). All participants signed an informed 
written consent prior to providing blood samples.
Subjects
We investigated the prevalence of VDR Fok1 
(rs2228570) T/C gene polymorphism in 125 breast cancer 
patients and 125 age matched healthy control subjects 
who were in follow up at the Department of Radiotherapy, 
King George Medical University, Lucknow. Selection of 
patients was mainly done using the following criteria: 
Any patient who had been histologically diagnosed for 
breast cancer with no concurrent chronic disease, had no 
infection with HIV, HBV or HCV, and aged between 18 
and 70 years. The age-matched controls were randomly 
selected from among a pool of healthy volunteers 
attending general health check-ups, and blood bank donors 
at King George Medical University. The sample size was 
determined using statistical approach (Snedecor et al., 
1989). The mean age of cases and control groups were 
44.472yrs and 40.88yrs respectively.
Blood sample collection and DNA isolation
After a careful review of the inclusion and exclusion 
criteria, blood specimens (2ml) were collected in tubes 
containing ethylene diamene tetra acetic acid (EDTA) as 
anticoagulant. The blood specimens were collected after 
obtaining informed consent after queries related to study 
and benefits expected would be given to participants. A 
peer reviewed, well drafted study proforma was filled 
for each subject providing patient personal, familial and 
clinical details. Blood samples were stored at -80 ̊C. Frozen 
blood samples were later thawed at room temperature and 
high molecular weight DNA was extracted by using the 
salting out procedure (Miller et al., 1988).
Genotyping of Fok1 (T>C rs2228570) 
Genotyping was performed by using polymerase 
chain reaction (PCR) and restriction fragment length 
polymorphism analysis (RFLP). The primer pair used 
for amplification of genomic DNA for genotyping of 
Fok1 polymorphism is shown in Table 1. The reaction 
conditions used for PCR amplification were as follows: 
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minimization and removal of steric collision.
Protein stability (ΔΔG) prediction
To examine the effect of point mutation on the change 
in protein stability, the difference in folding free energy 
was calculated using the I-mutant (I-mutant suite 3.0) 
program. I-mutant is a support vector machine (SVM) 
based tool used for the automatic prediction of protein 
stability changes upon single point mutation (Capriotti 
et al., 2006).
Molecular docking studies
Molecular interaction and binding analysis was done 
using Autodock (Version 4.0) suite and Cygwin interface 
in the Microsoft Windows Professional Version 2002, 
Intel® i7 processor, 3.30Ghz and 16 GB RAM DELL 
Machine. Molecular docking simulation methods were 
followed by searching of the best conformation of the wild 
type and mutated VDR protein and calcitriol complexes. 
Water molecules were deleted from the protein structures 
before docking simulation and hydrogen atoms were 
added to both wild type and mutated proteins. Kollman 
united charges and salvation parameters were added to 
the proteins. Gasteiger charge was added to the chemical 
compounds. The values were set to 55×61.25×70.835 Å 
in X, Y and Z axis of grid point. The default grid points 
spacing was 0.375 Å. Lamarckian Genetic Algorithm 
(LGA) was used for wild type and mutated proteins and 
calcitriol for docking calculations. The LGA parameters 
like population size (ga_pop_size), energy evaluations 
(ga_num_generation), mutation rate, crossover rate and 
step size were set to 150, 2500,000, 27,000, 0.02, 0.8 and 
0.2 Å, respectively. The LGA runs were set to 10 runs. 
All obtained 10 conformations of proteins and calcitriol 
complexes, were analyzed for the interactions and binding 
energy of the docked structure using Discovery Studio 
Visualizer version 2.5.5 and PyMol. The analyses were 
performed in Microsoft Windows 7 professional Version 
2002, Intel (R) i7 processor, 3.30 GHz CPU and 16.0 GB 
RAM DELL Machine.
Protein-protein interaction analysis
String database was used to identify the preferential 
functional partners of VDR (Szklarczyk et al., 2015). The 
protein-protein interaction analysis was performed using 
Hex version 6.3 (Macindoe et al., 2010), PatchDock Beta 
version 1.3 (Schneidman-Duhovny et al. 2005), and Fast 
Interaction Refinement in Molecular Docking (FireDock 
ref.1 server) (Mashiach et al. ,2008) bioinformatics tools.
Results
In-vitro
The size of the amplification product for the Fok1 
polymorphism was 272bp (Figure 2A). An intact 
amplification product indicated the absence of Fok1 
restriction site (F), while the presence of the Fok1 site (f) 
was indicated by two or three fragments. 
The undigested, single 272bp bands were genotyped 
as FF genotype (homozygote of common allele) in the 
agarose gel. The ff genotype (homozygote of infrequent 
Initial denaturation step of 4 min at 94ᵒC followed by 
30 cycles of 94ᵒC for 1min, annealing at 60oC for 1 min, 
and extension at 72ᵒC for 1min. A final extension step at 
72ᵒC for 4 min was also performed (Toptas et al., 2013).
The 272bp PCR product was digested with 1U of Fok1 
restriction enzyme (New England Biolabs) and incubated 
at 37oC (Toptas et al., 2013), overnight digestion was 
allowed to minimise partial digests. 6μl of the digested 
reaction mixture was electrophoresed for 1 hour at 100V 
and visualised on 2% agarose gels, stained with ethidium 
bromide. The size of the restriction endonuclease digested 
products was determined using a 100bp DNA ladder (G 
Biosciences). The presence of a given restriction site was 
assigned by lower case (f) and absence by upper case (F).
Statistical method
To evaluate the relationship between gene and 
genotype frequencies, Hardy-Weinberg equilibrium 
(HWE) was tested. The difference in distribution of the 
genotypes or alleles between cases and controls was tested 
using the chi-square statistic. Odds ratios (ORs) and 95% 
confidence intervals (CI) were calculated to estimate the 
risk of breast cancer. The association between genetic 
polymorphisms and breast cancer risk was evaluated using 
multivariate unconditional logistic regression analysis and 
p value <0.05 was considered as statistically significant. 
Statistical analysis was performed on SPSS Software 
(SPSS Inc., version 17.0).
Computational genomic analysis
The information of SNPs [SNP ID, amino acid 
position] of the human VDR gene was procured from the 
National Center for Biotechnology Information (NCBI) 
SNP database [http://www.ncbi.nlm.nih.gov/snp/] (Sherry 
et al., 2001). An in Silico exploration of the Fok1 SNP of 
VDR was performed using the Sorting Intolerant From 
Tolerant (SIFT) bioinformatics online tool (http://sift.
bii.a-star.edu.sg/www/SIFT_seq_submit2.html). SIFT 
predicts the effect of coding variants on protein function, 
based on sequence homology and physical properties of 
amino acids (Kumar et al., 2009).
Retrieval of the primary sequence of VDR
Primary FASTA sequence of VDR was procured 
from the Uniprot database (Uniprot ID-P11473), a 
comprehensive resource for protein sequence and 
annotation data (Apweiler et al., 2004).
Procurement and generation of the 3D structural model 
of VDR,Fok1 variant and calcitriol
The 3D structure of VDR (Figure 1) was procured 
from the RCSB protein Data Bank (Pdb.ID 1DB1). Due to 
absence of the experimental 3D structures of Fok1 variant, 
MODELLER 9.10 was used for the Homology Modeling 
and generation of the 3D structure of VDR variant (Eswar 
et al., 2006). Ramachandran Plot (RAMPAGE) was 
used for the validation and selection of the generated 3D 
structures (Hollingsworth et al., 2010). The structure for 
calcitriol (the active form of Vitamin D) was generated 
using the ChemSketch Software (ACD Lab Version 12.0) 
and CORINA online server. Chimera was used for energy 
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allele) generated two fragments of 198bp and 74bp while 
the heterozygotes (Bb) displayed three fragments (272bp, 
98bp, and 74bp). Figure 2B depicts the distribution of 
VDR Fok1 polymorphism in cases and controls.
The analysis included 125 breast cancer cases and 
125 healthy controls. Table 2 depicts genotype and allele 
frequencies in breast cancer cases and healthy controls. 
36% of the patients were found to be heterozygous (Ff) 
for the Fok1 polymorphism, 52% were homozygous 
(FF) and 12% were homozygous (ff). The respective 




5’-GAT GCC AGC TGG CCC TGG CAC TG-3’
Fok1 
Reverse
5’-ATG GAA ACA CCT TGC TTC TTC TCC CTC-3’
Table 1. Primer Sequences Used for PCR Amplification
Figure 1. Crystal Structure of Nuclear VDR Complexed 
to Vitamin D (as obtained from RCSB protein data bank; 
PDB ID: 1DB1).
Figure 2. Ethidium Bromide Stained 2% Agarose Gel 
Picture of Fok1 PCR Amplification (Panel A) and 
Digestion Products of VDR Gene (Panel B). A) The size 
of the amplification product for the Fok1 polymorphism 
was 272bp. Lane 1 shows a 100bp ladder. Lanes 2-10 
show single bands corresponding to the 272bp Fok1 
PCR product. B) Ethidium bromide stained 2% agarose 
gel picture of Fok1 digested amplification products of 
VDR gene: The upper bands represent F (T allele), the 
lower bands represent f (C allele). Lane 1 shows a 100bp 
ladder. Lanes 2, 6, and 9 show Ff heterozygotes; lanes 
3,4,7,8 and 10 show FF homozygotes; lane 5 shows ff 
homozygote.






OR 95% CI Χ2 p values Bonferroni 
corrected p values
N % N %
Genotype FF 65 52 68 54.40 0.908 0.55 - 1.49 0.15 0.704 1
Ff 45 36 56 44.80 0.693 0.42 - 1.15 2.01 0.156 0.469
ff 15 12 1 0.80 16.909 2.20 - 130.11 13.09 0.0003 0.001
Allele F 175 70 192 76.80 0.705 0.47 - 1.05 2.96 0.085 0.171
f 75 30 58 23.20 1.419 0.95 - 2.11 2.96 0.085 0.171
Average power, 0.816; OR, odds ratio; CI, confidence interval.
Table 2. Genotype and Allele Frequencies in Breast Cancer Cases and Healthy Controls
Figure 3. The Genotype, Allele Frequencies, in Fok1 Cases and Controls
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44.8%, 54.4% and 0.8%. The VDR Fok1 ff genotype 
was significantly increased in breast cancer patients as 
compared to controls (Figure 3). The Fok1 ff genotype 
was significantly associated with an increased risk of 
breast cancer (p=0.001; χ2=13.09; OR=16.909; %95 
CI=2.20 - 130.11).
In-silico
The computational genomic analysis and exploration 
of the Fok1 variant shows that Fok1 is a non-synonymous 
SNP and lies in the coding/exonic region (Table 3). The 
Fok1 polymorph persists its genomic alteration at protein 
level and shows amino acid substitution at position 1 (M1I; 
Methionine to Isoleucine) (Figure 4A). Point mutation in 
VDR caused a loss of protein stability, and the difference 
in free folding energy (ΔΔG) of the SNP variants was 
analysed using I mutant program. Fok1 SNP showed ΔΔG 
energy of -0.40 kcal/mol.
A significant decrease in the total number of intra-
molecular H-bonds was observed in the Fok1 SNP variant 
compared to the wild type VDR protein. Wild type VDR 









Gene desc Vitamin D (1,25- dihydroxyvitamin D3) receptor [Source:HGNC Symbol;Acc:12679]
Protein Family ID ENSFM00630001050580
Protein Family Desc Vitamin d3 receptor (VDR); 1, 25 dihydroxyvitamin d3 receptor nuclear receptor; 
subfamily 1 group i member 1.
Transcript status KNOWN
Substitution effect of SNP on Protein 
sequence amino acid
M1I
ΔΔG value prediction of VDR protein -0.40 Kcal/Mol
Table 3. Computational Analysis of Fok1 VDR SNP by the SIFT Tool
Figure 4. Computational Genomic Analysis of SNP: (A) The position of SNP induced amino acid substitution in Fok1 
variant (Position 1: Methionine to Isoleucine) of VDR (B) Change in number of intra-molecular H-bonds upon point 
mutation (wild type VDR: 556; Fok1 variant: 505).
S.No. Protein Ligand Binding Energy (kcal/mol) Ki (μM) Hydrogen Bond Distance (Å)
M)
1 VDR(wild type) Calcitriol -7.39 214.66 :LYS264:HZ3 -  :Calcitriol:O28 2.01639
:Calcitriol:H71 - :PRO344:O 1.8552
2 VDR(Fok1 variant) Calcitriol -5 3.82 :HIS397:HE2 – : Calcitriol:O9 2.23125
:Calcitriol:H70 - :SER278:OG 2.15288
:Calcitriol:H71 - :TYR236:OH 1.93697
Table 4. Molecular Interaction and Binding Analysis of VDR with Calcitriol
Sana Raza et al
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variant showed 505 intra-molecular H-bonds (Figure 4B). 
The molecular interaction analysis of wild type VDR with 
calcitriol and Fok1 variant with calcitriol is illustrated in 
Table 4.  The Fok1 variant (-5.0 kcal/mol) has a lower 
binding energy in comparison to wild type VDR protein 
(-7.39 kcal/mol). 
The total number of binding (amino acid) residues 
found between wild type VDR and calcitriol were 19, 
however, a decrease in the total number of binding residues 
was seen upon point mutation, and only 10 binding 
residues were seen to be formed between the Fok1 variant 
and calcitriol.
The retinoid X receptor (RXR) is a well-established 
functional partner of VDR (Orlov et. al. 2012). String 
database network depicting most preferential functional 
partners of VDR (Figure 5). The protein-protein interaction 
analysis of liganded wild type VDR (VDR+Calcitrol) 
to RXR (Patch Dock: 15456; Hex: -727.3; FireDock: 
-36.75) and liganded Fok1 variant to RXR shows that 
liganded VDR variant (Fok1) has a lower binding 
score (PatchDock-15064; Hex: -717; Firedock: -10.10) 
compared to wild type VDR (Table 5). Both forms of the 
RXR (RXR alpha and RXR beta) were analysed.
Discussion
The Fok1 polymorphism lies in exon 2, and alters the 
start codon ATG, leading to the substitution of methionine 
by isoleucine at position 1 (M1I). This polymorphism 
leads to a substitution from T to C (ATG to ACG) at 
the first initiation codon (ATG) leading to an altered 
translation start site. The presence of Fok1 restriction site 
(denoted f) results in expression of the full isoform of VDR 
protein (427 residues). The shorter isoform (424 residues 
long) is produced in the absence of Fok1 site (denoted F) 
(Jurutka et al., 2001). The production of two differently 
sized proteins may affect VDR function. VDR is known to 
heterodimerize with RXR, recruiting other transcriptional 
co-activators that regulate target gene transcription. 
Our study shows that SNPs may hamper the normal 
interaction of liganded VDR with RXR at protein 
level. Statistical potential algorithms are often used 
for prediction of changes in stability of proteins, upon 
point mutation (Parthiban et al., 2007). The analysis 
of difference in free folding energy (ΔΔG) of the SNP 
variant shows that Fok1 SNP variant has ΔΔG energy 
of-0.40 kcal/mol. The output of the predicted free energy 
change (ΔΔG) classifies the results into one of the three 
classes i.e. largely stable (ΔΔG>0.5kcal/mol), neutral 
(-0.5≤ΔΔG≤0.5 kcal/mol) or largely unstable (ΔΔG<−0.5 
kcal/mol). This indicates a decrease in stability of VDR 
upon point mutation, as a protein prefers to stay in its 
lowest energy conformation i.e. ΔΔG=0 (Du et al. 2016). 
A significant decrease in total number of intra-molecular 
H-Bonds was also observed in the Fok1 variant compared 
to wild type VDR protein (wild type VDR: 556; Fok1: 
505). Hydrogen bonds contribute favourably to protein 
stability (Pace et al., 2014). A reduction in the total number 
of intramolecular H-bonds also indicates a decrease in 
the overall protein stability, upon point mutation. The 
binding affinity analysis of wild type VDR and Fok1 
variant with calcitriol shows that the SNP causes a loss 
in affinity of VDR for calcitriol. The Fok1 SNP variant 
shows lower binding energy with calcitriol (-5.0 kcal/
mol) compared to the wild type VDR protein (-7.39 kcal/
mol). The more negative the energy, the more effective 
S. No. Receptor Ligand Binding Score by Patch Dock Binding Score by HEX Binding Score by Fire Dock
1 WT-VDR+ Calcitriol RXR-Alpha 15456 -727.3 -36.75
2 Fok1-VDR+ Calcitriol RXR-Alpha 15064 -717 -10.1
3 WT-VDR+ Calcitriol RXR-Beta 16558 -837.6 -22.22
4 Fok1-VDR+ Calcitriol RXR-Beta 16080 -715.8 -21.69
Table 5. Protein-Protein Interaction Analysis of Liganded Wild Type VDR and Liganded SNP Variants of VDR with 
RXR (Alpha and Beta)
Figure 5. String Database Network Showing Preferential 
Functional Partners of VDR.
Figure 6. Molecular Mechanism of Cancer Susceptibility 
Associated with the SNPs of the Nuclear Hormone 
Receptor VDR
Asian Pacific Journal of Cancer Prevention, Vol 20 205
DOI:10.31557/APJCP.2019.20.1.199
Vitamin D Receptor Gene Fok1 Polymorphism and Risk of Breast Cancer
binding. Further, the protein-protein interaction analysis 
of liganded wild type VDR (VDR+Calcitrol) to RXR 
(Patch Dock: 15456; Hex: -727.3; Firedock: -36.75) and 
liganded Fok1 variant to RXR shows that liganded VDR 
Fok1 (PatchDock: 16080; Hex: -715.8; Firedock: -21.69) 
and RXR alpha have lower binding score as compared 
to wild type VDR and RXR alpha. A similar trend was 
observed with RXR beta form. The Fok1 SNP (PatchDock: 
16080; Hex: -715.8; FireDock: -21.69) variant showed 
a lower binding score to RXR-Beta as compared to the 
wild type VDR protein (PatchDock: 16558; Hex:-837.6; 
Firedock: -22.22). A significant reduction in the number 
of intermolecular H-Bonds was also observed between 
the liganded Fok1 SNP variant of VDR and RXR. This 
indicates that SNP may hamper the normal interaction of 
liganded VDR with the RXR at protein level. The aetiology 
of any specific cancer may probably be associated with 
a set of genetic variants, some of which could adversely 
interact with certain environmental factors. VDR regulates 
gene expression in a ligand-dependent manner (Dwivedi 
et al., 2002). It is also involved in micro-RNA directed 
post-transcriptional mechanisms (Campbell, 2014). 
VDR has also been reported to be involved in estrogen 
related pathways, immunomodulation, insulin-like growth 
factor signaling and known to affect gene expression in a 
ligand-dependent manner (Yang et al., 2017).
Based on the above observations, we tried to elucidate 
the mechanism of cancer susceptibility associated with 
the SNPs of VDR at protein level (Figure 6). The binding 
affinity analysis of liganded wild type VDR and liganded 
Fok1 variant to RXR shows that the liganded Fok1 
variant has a lower binding energy as compared to wild 
type VDR and RXR. This indicates that the SNPs may 
cause an impairment of the normal interaction of VDR 
with its heterodimeric partner RXR at protein level. The 
liganded VDR-RXR heterodimerization is functionally 
linked to VDRE binding and recognition in the DNA 
sequence of vitamin D regulated genes. The SNPs may 
not only cause a loss in affinity of VDR to calcitriol, but 
also lead to the impairment of the normal interaction of 
VDR to RXR at protein level.VDR is known to regulate 
about 3,000 genes in the human genome, including some 
genes like hp21 and hFOXO1, which are involved in cell 
cycle control (proliferation, differentiation, migration and 
death) and apoptosis (Anderson et al., 2011). The other 
genetic polymorphisms of VDR may also have a role in 
modulating the risk of breast cancer by affecting gene 
splicing, transcription factor binding, etc. 
Over the past decades, extensive research has shown 
that low sunlight exposure and deficiency of vitamin D are 
associated with increase in risk of extra-skeletal diseases 
like cancer (Bikle et al., 2016; Wang et al., 2017). VDR 
has been suggested to control the expression of a number 
of genes that are associated with cell proliferation and 
differentiation. This indicates that VDR may play a key 
role in prevention of cancer (Gil et al., 2018). To date, 
very few studies have shown the importance of gene 
variants as prognostic markers unequivocally. However, 
a small percentage of the known genes have been 
adequately studied till yet, therefore, the investigation 
of SNPs still remains active. SNP association studies 
targeting cancer may be divided into two broad categories 
i.e. investigation of susceptibility and investigation of 
outcomes. The outcomes seek to determine the prognostic 
information for survival, response to pharmacological 
intervention, or complications. SNP variants may be 
associated to outcome and, hence, could be applied to 
making clinical decisions. Further research is needed to 
explore the functional mechanisms behind the observed 
effects of these polymorphisms. The assessment of VDR 
polymorphisms is essential for identification of the groups 
at risk and to develop strategies to target it. Thus, SNPs in 
VDR may cause alterations in the major molecular actions 
of VDR, namely ligand binding, heterodimerization, 
and transactivation. Breast cancer risk and pathogenesis 
in females can be influenced by SNPs and the analysis 
of SNPs in breast cancer research has pleiotropic 
implications for clinical and public health issues, as well 
as cancer biology. Computer-based structural & genomic 
analysis of SNPs may play a significant role in cancer 
management.
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